Discover
INSP
Inspire Medical Systems, Inc.
52.91
1 x 52.82
1 x 52.99
bid
ask
-
0.36
0.68%
12:39 PM
timesize
| Ytd | -42.63% | |
| 1y | -57.72% |
51.84
day range
53.50
38.91
52 week range
147.03
| Open | 52.29 | Prev Close | 53.27 | Low | 51.84 | High | 53.50 | Mkt Cap | 1.53B |
| Vol | 144.38K | Avg Vol | 1.17M | EPS | 2.58 | P/E | 20.65 | Forward P/E | 116.28 |
| Beta | 0.71 | Short Ratio | 4.32 | Inst. Own | 123.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 44.38 | 200-d Avg | 70.03 | 1yr Est | 52.38 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2026-05-04 | 2026-03 | 0 | 0.1 | 0.46 | 127.78% |
| 2026-02-11 | 2025-12 | 0.69 | 1.65 | 0.96 | 139.13% |
| 2026-02-11 | 2025-12 | 0.69 | N/A | N/A | N/A |
| 2025-11-03 | 2025-09 | 0 | N/A | N/A | N/A |
| 2025-11-03 | 2025-09 | 0 | 0.38 | 0.53 | 353.33% |
| 2025-08-04 | 2025-06 | 0.22 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2026-07-01 | Freedom Capital Markets | Upgrade | Buy | |
| 2026-06-23 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| 2026-05-07 | Oppenheimer | Upgrade | Perform | Perform |
| 2026-05-05 | JP Morgan | Upgrade | Neutral | Neutral |
| 2026-05-05 | Piper Sandler | Downgrade | Overweight | Neutral |
| 2026-05-05 | Stifel | Upgrade | Buy | Buy |
Profile
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2025-08-28 | BUCHHOLZ RICHARD | Chief Financial Officer | 50.77K | Sale |
| 2026-02-19 | HERBERT TIMOTHY P | Chief Executive Officer | 163.49K | Stock Award(Grant) |
| 2026-02-19 | KELLY JASON P | Officer | 19.95K | Stock Award(Grant) |
| 2026-02-19 | MANN MELISSA | Officer | 23.61K | Stock Award(Grant) |
| 2026-05-07 | MCCORMICK SHAWN T | Director | 30.71K | Sale |
| 2026-04-29 | MEAD DANA G JR | Director | 26.21K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-03-30 | BlackRock Inc | 3.55M | 0.00 | 12.32% |
| 2025-12-30 | Vanguard Group Inc | 2.95M | 0.00 | 10.25% |
| 2026-03-30 | Deerfield Management Co | 2.70M | 0.00 | 9.38% |
| 2026-03-30 | Wellington Management Company LLP | 2.54M | 0.00 | 8.80% |
| 2026-03-30 | Vanguard Portfolio Management, LLC | 1.64M | 0.00 | 5.68% |
| 2026-03-30 | Morgan Stanley - Brokerage Accounts | 1.45M | 0.00 | 5.03% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-03-30 | Vanguard Health Care Inv | 2.09M | 0.00 | 7.27% |
| 2026-06-29 | iShares Core S&P Small-Cap ETF | 1.58M | 0.00 | 5.48% |
| 2026-06-29 | Vanguard Total Stock Mkt Idx Inv | 914.15K | 0.00 | 3.17% |
| 2026-06-29 | iShares Russell 2000 ETF | 755.05K | 0.00 | 2.62% |
| 2026-06-29 | Vanguard Small Cap Index | 662.41K | 0.00 | 2.30% |
| 2025-12-30 | Xtrackers S&P 500 Swap ETF 1C | 505.36K | 0.00 | 1.75% |
Dividend
| Dividend | Date |
|---|---|
| 9 | 2008-01-09 |